BackBellus Health Overview

Bellus Health Total Revenue

Bellus Health's total revenue is $3.2B, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$1.65B
41278850.95% YoY

As of Sep 2023

Annual Revenue (TTM)

$3.17B
19833329.33% YoY

Trailing 12 months ending Sep 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Bellus Health (BLU) FAQ

Bellus Health (BLU) currently reports a total revenue of $3.2B as of September 2023. That compares with $16K in the prior-year period — up 19833329.3% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Bellus Health's total revenue history and peer comparisons.

Bellus Health's total revenue increased from $16K to $3.2B — a 19833329.3% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellus Health's total revenue of $3.2B is lower than the Healthcare sector average of $110B. That is roughly 97.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Bellus Health reported $3.2B in total revenue as of September 2023. That compares with $16K in the prior-year period — up 19833329.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $3.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Bellus Health, and consider following BLU for alerts when major investors trade the stock.